To investigate the protective role of sophocarpine in pulmonary hypertension.
Used preclinical models to assess the effects of sophocarpine
Evaluated pulmonary hypertension indicators
Conducted statistical analyses of therapeutic effects
Sophocarpine showed a significant protective effect in the pulmonary hypertension model
Indications of reduced symptoms and improved outcomes were observed
Potential for sophocarpine as a therapeutic agent for pulmonary hypertension was established
Abstract
Our study provides clear evidence that SOP has a significant protective effect in the PH model and is expected to be a promising therapeutic agent for PH.